Could this humble autumn fruit hold clues to future cancer research?
A 2025 study published in the Tropical Journal of Natural Product Research investigated whether natural compounds found in persimmons (Diospyros kaki) might interact with biological processes involved in breast cancer.
Researchers identified six compounds of interest, including gallic acid, ferulic acid, ellagic acid, and chlorogenic acid.
They examined potential connections between these compounds and breast cancer-associated proteins, including those involved in hormone signaling, DNA repair, and cell growth regulation.
The analysis identified 23 breast-cancer-related targets and highlighted several genes involved in important cancer-related pathways. These findings offer promising leads for further investigation.
Researchers identified six compounds of interest, including gallic acid, ferulic acid, ellagic acid, and chlorogenic acid.
They examined potential connections between these compounds and breast cancer-associated proteins, including those involved in hormone signaling, DNA repair, and cell growth regulation.
The analysis identified 23 breast-cancer-related targets and highlighted several genes involved in important cancer-related pathways. These findings offer promising leads for further investigation.
A separate 2020 laboratory study found that flavonoids extracted from persimmon leaves inhibited the growth of human breast cancer cells, along with other cancer cell types (liver, colorectal, prostate).
Researchers found these compounds affected cellular processes, including oxidative stress and cell death.
These results suggest that persimmon-derived compounds may have biological activities worth exploring in future cancer research.